Skip to content

Clinical trials

Phase 2/3 Cognitive Dysfunction trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cognitive Dysfunction Phase: Phase 2/3 Country / region: United States Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20041
20061
20071
20141
20152
20171
20182
20211
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Active, not recruiting1
Recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Mandos LLC2
AgeneBio1
Anne Comi, MD1
Columbia University1
Mclean Hospital1
New York State Psychiatric Institute1
Oregon Health and Science University1
University of California, San Diego1
University of Maryland, Baltimore1
University of Southern California1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cognitive Dysfunction12
Alzheimer Disease2
Deglutition Disorders2
Disease2
Mobility Limitation2
Niemann-Pick Disease, Type C2
Schizophrenia2
AIDS Dementia Complex1
Alcoholism1
Brain Diseases1

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.